Evaxion Biotech A/S (EVAX)
NASDAQ: EVAX
· Real-Time Price · USD
5.43
0.69 (14.56%)
At close: Oct 03, 2025, 3:59 PM
5.30
-2.39%
After-hours: Oct 03, 2025, 07:48 PM EDT
Evaxion Biotech A/S Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Nov 14, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 14.75M | 17.84M | 5.05M | 4.58M | 7.99M | 11.73M | 5.58M | 2.6M | 7.12M | 10.24M | 13.18M | 17.85M | 25.25M | 31.41M | 32.17M | 11.94M | 18.8M | 26.95M |
Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 26.37K | n/a | 50.5K | n/a | n/a | n/a | n/a | n/a | n/a |
Long-Term Investments | 464.01K | n/a | 44K | n/a | 463.01K | n/a | 29K | n/a | 638.99K | n/a | 209K | n/a | n/a | n/a | n/a | n/a | n/a | 232K |
Other Long-Term Assets | 184.99K | 7.4M | 162K | 10.61M | 165.01K | 10.92M | 167K | 7.63M | 165.01K | 10.25M | 156K | 9.59M | 518K | 334K | n/a | 2.22M | 1.61M | 133K |
Receivables | 864.02K | n/a | 1.86M | n/a | 2.71M | n/a | 1.07M | n/a | 4.25M | n/a | n/a | n/a | 1.3M | 1.38M | 1.9M | n/a | n/a | 1.61M |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -4.25K | n/a | -2.49M | n/a | n/a | n/a | n/a | n/a | n/a | 3.9M |
Other Current Assets | -18 | n/a | 900K | n/a | -259 | n/a | -32 | 4.25M | n/a | n/a | n/a | n/a | 87K | 10K | n/a | 457K | 265K | 19K |
Total Current Assets | 18.18M | 17.84M | 8.77M | 4.58M | 10.7M | 11.73M | 8.35M | 2.6M | 11.37M | 10.24M | 13.97M | 17.85M | 28.53M | 35.38M | 34.7M | 16.32M | 23.43M | 32.49M |
Property-Plant & Equipment | 3.62M | n/a | 3.51M | n/a | 3.9M | n/a | 4.34M | 4.31M | 4.58M | n/a | 4.67M | n/a | 4.87M | 5.28M | 5.37M | 5.35M | 2.28M | 1.79M |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 85K | 91K | 93K | 95K | 97K | 96K |
Total Long-Term Assets | 4.27M | 7.4M | 3.72M | 10.61M | 4.53M | 10.92M | 4.54M | 11.94M | 5.39M | 10.25M | 5.04M | 9.59M | 5.47M | 5.7M | 5.46M | 7.8M | 4.23M | 2.43M |
Total Assets | 22.45M | 25.24M | 12.48M | 15.19M | 15.23M | 22.65M | 12.89M | -75.09M | 16.75M | -64.81M | -58.94M | 27.45M | 34M | 41.08M | 40.16M | 24.12M | 27.66M | 34.92M |
Account Payables | 2.5M | n/a | 2.97M | n/a | 2.56M | n/a | 2.69M | n/a | 1.69M | n/a | 2.08M | n/a | 2.44M | 2.49M | 2.85M | 538K | 1.55M | 3.41M |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.49M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Short-Term Debt | 184K | n/a | 159K | n/a | 158K | n/a | 159K | 150K | 152K | n/a | 136K | n/a | 119K | 125K | 126K | 159K | n/a | n/a |
Other Current Liabilities | 1.13M | n/a | 67K | n/a | 48.12K | n/a | 3.91M | -2.76M | 402K | n/a | 1.24M | n/a | 625K | 1.02M | 1.03M | 2.91M | 3.11M | 2.55M |
Total Current Liabilities | 5.32M | n/a | 4.37M | n/a | 3.82M | n/a | 7.08M | 4.69M | 4.05M | n/a | 3.76M | n/a | 4.41M | 4.69M | 4.32M | 3.92M | 4.8M | 6.02M |
Long-Term Debt | 9.03M | n/a | 8.01M | n/a | 8.26M | n/a | 8.49M | n/a | 8.08M | n/a | 1.95M | n/a | 7.34M | 7.72M | 1.04M | 1.1M | n/a | n/a |
Other Long-Term Liabilities | 158K | 14.92M | 141K | 15.11M | 145.33K | 20.05M | 148.69K | n/a | 147K | n/a | 6.06M | n/a | 141K | 150K | 153K | 157K | 53K | 52K |
Total Long-Term Liabilities | 10.9M | 14.92M | 9.77M | 15.11M | 10.16M | 20.05M | 10.53M | 14.68M | 10.17M | 13.91M | 9.96M | 13.9M | 9.45M | 10.01M | 3.4M | 3.54M | 1.03M | 1.1M |
Total Liabilities | 16.22M | 14.92M | 14.14M | 15.19M | 13.98M | 20.05M | 17.62M | 14.68M | 14.22M | 13.91M | 13.72M | 13.9M | 13.85M | 14.69M | 7.73M | 7.47M | 5.83M | 7.12M |
Total Debt | 11.28M | n/a | 10.1M | n/a | 10.49M | n/a | 10.87M | 9.99M | 10.49M | n/a | 2.25M | n/a | 9.72M | 10.29M | 3.69M | 3.87M | 1.11M | 1.11M |
Book Value | 6.23M | 10.32M | -1.65M | n/a | 1.25M | 2.6M | -4.73M | -89.76M | 2.54M | -78.72M | -72.66M | 13.55M | 20.15M | 26.39M | 32.44M | 16.65M | 21.83M | 27.8M |
Book Value Per Share | 1.29 | 9.34 | -1.54 | n/a | 0.93 | 2.23 | -6.92 | -129.81 | 3.75 | -122.13 | -120.4 | 22.74 | 34.74 | 45.57 | 59.87 | 34.69 | 46.10 | 62.48 |
Common Stock | 11.82M | 11.82M | 10.52M | 8.73M | 8.24M | 7.96M | 5.9M | 4.41M | 4.39M | 4.22M | 3.89M | 3.86M | 3.84M | 3.75M | 3.75M | 3.13M | 3.13M | 3.13M |
Retained Earnings | -124.95M | -120.11M | -118.54M | -114.9M | -112.97M | -112.03M | -107.97M | -89.76M | -84.26M | -78.72M | -72.66M | -65.76M | -60.33M | -55.88M | -50.43M | -42.14M | -37.47M | -31.08M |
Comprehensive Income | -3.08M | 118.61M | -3.6M | 106.25M | 105.98M | 106.67M | 9.89M | 82.61M | 82.4M | 81.08M | -3.65M | 75.44M | 76.63M | 78.51M | 79.11M | 55.66M | 56.17M | 55.74M |
Shareholders Equity | 6.23M | 10.32M | -1.65M | 74K | 1.25M | 2.6M | -4.73M | -89.76M | 2.54M | -78.72M | -72.66M | -65.76M | 20.15M | 26.39M | -50.43M | 16.65M | 21.83M | 27.8M |
Total Investments | 464.01K | n/a | 44K | n/a | 463.01K | n/a | 29K | n/a | 638.99K | 26.37K | 209K | 50.5K | n/a | n/a | n/a | n/a | n/a | 232K |